Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001883640 | SCV002140548 | benign | Amyotrophic lateral sclerosis type 4; Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2 | 2023-11-15 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002386648 | SCV002694341 | uncertain significance | Inborn genetic diseases | 2023-04-05 | criteria provided, single submitter | clinical testing | Unlikely to be causative of SETX-related juvenile amyotrophic lateral sclerosis (AD) Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Gene |
RCV002464496 | SCV002759127 | uncertain significance | not provided | 2022-11-30 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV004770253 | SCV005381034 | uncertain significance | not specified | 2024-08-15 | criteria provided, single submitter | clinical testing | Variant summary: SETX c.991A>G (p.Ile331Val) results in a conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 8.8e-05 in 251420 control chromosomes. This frequency is not significantly higher than estimated for a pathogenic variant in SETX causing Amyotrophic Lateral Sclerosis Type 4, allowing no conclusion about variant significance. To our knowledge, no occurrence of c.991A>G in individuals affected with Amyotrophic Lateral Sclerosis Type 4 and no experimental evidence demonstrating its impact on protein function have been reported. ClinVar contains an entry for this variant (Variation ID: 1379186). Based on the evidence outlined above, the variant was classified as uncertain significance. |
Prevention |
RCV004542153 | SCV004763623 | uncertain significance | SETX-related disorder | 2023-11-18 | no assertion criteria provided | clinical testing | The SETX c.991A>G variant is predicted to result in the amino acid substitution p.Ile331Val. To our knowledge, this variant has not been reported in the literature. Of note, a different missense variant at the same position (p.Ile331Lys) has been reported in an individual with ataxia with oculomotor apraxia (Nanetti et al. 2013. PubMed ID: 23941260). At this time, the clinical significance of the c.991A>G (p.Ile331Val) variant is uncertain. |